Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities

被引:24
|
作者
Delgado, Carolina [1 ,2 ,3 ]
Vergara, Rodrigo C. [3 ,4 ]
Martinez, Melissa [1 ,2 ]
Musa, Gada [5 ,6 ,7 ,8 ]
Henriquez, Fernando [5 ,6 ,7 ,8 ]
Slachevsky, Andrea [3 ,5 ,6 ,7 ,8 ]
机构
[1] Hosp Clin Univ Chile, Dept Neurol, Santos Dumont 999, Santiago 8380456, Chile
[2] Hosp Clin Univ Chile, Dept Neurosurg, Santos Dumont 999, Santiago 8380456, Chile
[3] Univ Chile, Fac Med, Dept Neurosci, Santiago, Chile
[4] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile
[5] Gerosci Ctr Brain Hlth & Metab GERO, Ave Salvador 486, Santiago, Chile
[6] Univ Chile, Fac Med, Neuropsychol & Clin Neurosci Lab LANNEC, Physiopathol Dept,ICBM,East Neurosci Dept, Santiago, Chile
[7] Hosp del Salvador, Memory & Neuropsychiat Clin CMYN, Neurol Dept, Santiago, Chile
[8] Univ Chile, Santiago, Chile
关键词
Activities of daily living; Alzheimer's disease; apathy; cognitive decline; depression; disability; elderly; memory; neuropsychiatric symptoms; MILD COGNITIVE IMPAIRMENT; DAILY LIVING QUESTIONNAIRE; INSTRUMENTAL ACTIVITIES; DIAGNOSTIC-CRITERIA; OLDER-ADULTS; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; INCIDENT DEMENTIA; APATHY; VALIDATION;
D O I
10.3233/JAD-180771
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Neuropsychiatric symptoms and cognitive impairment are independent contributors of functional impairment in activities of daily living (ADL) in Alzheimer's disease (AD) patients. ADL could be divided according to its complexity in three subdomains: basic (BADL), instrumental (IADL), and advanced (a-ADL). Objective: Studying the cognitive and neuropsychiatric determinants of BADL, IADL, and a-ADL in normal cognitive elders and AD patients. Methods: 144 subjects were graduated using the clinical dementia rating (CDR) in CDR = 0, n= 52 (control group) and 92 AD patients CDR = 0.5, n= 34 and CDR = 1&2, n= 58. They were assessed with measures of cognitive performance and neuropsychiatric symptoms that were included in regression models to measure the best predictors for each ADL subdomain at every CDR status. Results: AD patients were significantly older, and had significantly more severe functional impairment, neuropsychiatric symptoms, and cognitive decline than controls. The best predictors of functional impairment in controls and CDR = 0.5 AD patients were neuropsychiatric symptoms; in the CDR 0.5 patients, apathy severity was the most important determinant of IADL and a-ADL impairment. While in the CDR 1&2 AD patients, cognitive impairment was the principal determinant of functional impairment, being memory the best determinant of IADL and a-ADL impairment, while global cognition was of BADL impairment. Conclusions: The contribution of cognitive impairment and neuropsychiatric symptoms varied according to the subdomain of ADL, and the CDR. In very mild AD and controls the neuropsychiatric symptoms are the best predictors of more complex ADL impairment, while cognitive impairment is more important at mild to moderate states of AD.
引用
收藏
页码:381 / 392
页数:12
相关论文
共 50 条
  • [1] Executive dysfunction in Alzheimer's disease: Association with neuropsychiatric symptoms and functional impairment
    Chen, ST
    Sultzer, DL
    Hinkin, CH
    Mahler, ME
    Cummings, JL
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 10 (04) : 426 - 432
  • [2] Neuropsychiatric symptoms, functional impairment and executive ability in Thai patients with Alzheimer's Disease
    Senonarong, V
    Poungvarin, N
    Jamjumras, P
    Sriboonroung, A
    Danchaivijit, C
    Udomphanthuruk, S
    Cummings, JL
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 (01) : 81 - 90
  • [3] Neuropsychiatric Symptoms and Global Functional Impairment along the Alzheimer's Continuum
    Wadsworth, Lauren P.
    Lorius, Natacha
    Donovan, Nancy J.
    Locascio, Joseph J.
    Rentz, Dorene M.
    Johnson, Keith A.
    Sperling, Reisa A.
    Marshall, Gad A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 34 (02) : 96 - 111
  • [4] May neuropsychiatric symptoms be a potential intervention target to delay functional impairment in Alzheimer's disease?
    Politis, Antonios M.
    Alexopoulos, Panagiotis
    Vorvolakos, Theofanis
    INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 (06) : 689 - 691
  • [5] Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
    Ribeiro, Deidiane Elisa
    Petiz, Lyvia Lintzmaier
    Glaser, Talita
    Oliveira-Giacomelli, Agatha
    Andrejew, Roberta
    Saab, Fernando de Azevedo Ribeiro
    Milanis, Milena da Silva
    Campos, Henrique Correia
    Sampaio, Vanessa Fernandes Arnaud
    La Banca, Sophia
    Longo, Beatriz Monteiro
    Lameu, Claudiana
    Tang, Yong
    Resende, Rodrigo Ribeiro
    Ferreira, Sergio T.
    Ulrich, Henning
    NEUROPHARMACOLOGY, 2023, 226
  • [6] Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease
    You, S. Christine
    Walsh, Christine M.
    Chiodo, Louis A.
    Ketelle, Robin
    Miller, Bruce L.
    Kramer, Joel H.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (03) : 863 - 869
  • [7] Neuropsychiatric symptoms in Alzheimer's disease
    Allegri, R
    Polero, A
    Gimenez, M
    Serrano, C
    Lon, L
    Taragano, F
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 94 - 94
  • [8] Relationship between Neuropsychiatric Symptoms and Activities of Daily Living in Alzheimer's Disease
    Ryu, Seon-Young
    Lee, Sang-Bong
    Kim, Tae-Woo
    Song, In-Uk
    Oh, Eun-Young
    Choi, Hye-Yeoung
    ANNALS OF GERIATRIC MEDICINE AND RESEARCH, 2010, 14 (03): : 131 - 138
  • [9] Course of neuropsychiatric symptoms in Alzheimer's disease
    Ryu, Seung-Ho
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 : S40 - S41
  • [10] Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease, and its Relationship with Cognitive Impairment
    Fernandez-Martinez, M.
    Molano, A.
    Castro, J.
    Zarranz, J. J.
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (06) : 517 - 526